尤金尼亚属的物种:生物活性效应和毒性
Thaís E Fischer1, Elisandra Detoni1, Isabela M M S Sola1
1Graduate Program in Food Science and Technology, State University of Ponta Grossa (UEPG), Ponta Grossa, 84030-900, Brazil.
Nutrition reviews
|July 18, 2025
概括
巴西Eugenia属从其果实和叶子中提供有价值的生物活性化合物,但仍未得到充分利用. 研究强调它们的功能性食品潜力,强调需要安全评估和进一步调查.
科学领域:
- * 药理学和植物化学
- * 营养科学 营养科学
- * 食品科学与技术 * 食品科学与技术
背景情况:
- *原产于巴西的Eugenia属,拥有富含生物活性化合物和营养素的物种.
- * 尽管尤金尼亚果实和其他植物部位具有潜力,但它们在各种应用中在很大程度上未得到充分利用.
- *现有研究表明,它具有重要的营养价值和多种植物化学物质的存在.
研究的目的:
- * 审查和综合有关Eugenia物种生物活性化合物和活动的信息.
- * 调查尤金亚树叶,水果和种子的生物可访问性和毒性.
- * 探索Eugenia物种在功能性食品应用中的潜力,并刺激进一步的研究.
主要方法:
- * 关于Eugenia物种研究的综合文献综述.
- *分析报告中的生物活性化合物,包括化合物,胡卜素,类,类和类.
- * 评估已记录的生物活性,如抗氧化,抗增殖,抗炎,抗血糖和抗菌作用.
主要成果:
- * 欧吉尼亚物种是丰富的化合物,胡卜素,类,类,类和类的来源.
- *这些化合物表现出广泛的生物活性,包括抗氧化,抗炎和抗菌性质.
- *提取物和精油可能具有毒性,需要进一步研究安全性和提取方法.
结论:
- * 欧吉尼亚物种具有发展成为功能性食品和营养保健品的巨大潜力.
- *进一步的研究对于了解生物可访问性,毒性和优化提取技术以确保安全消费至关重要.
- *建议通过体内研究来阐明生物活性效应,以支持产品开发.
相关概念视频
01:27Effects of Chemicals: Overview
1.4K
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
1.4K
01:26Physical Properties of Amines
3.5K
Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
3.5K
01:23Drugs Acting on Autonomic Ganglia: Stimulants
1.5K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.5K
01:26Toxic Reactions: Overview
1.2K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.2K
01:25Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
01:20Antiepileptic Drugs: Potassium Channel Activators
280
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
280